Owens & Minor Inc. (OMI)
NYSE: OMI
· Real-Time Price · USD
7.79
-0.18 (-2.26%)
At close: Jun 13, 2025, 3:59 PM
7.78
-0.13%
After-hours: Jun 13, 2025, 06:08 PM EDT
Owens & Minor Revenue Breakdown
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 |
|---|---|---|---|
| Patient Direct Revenue | 2.68B | 2.55B | 2.06B |
| Patient Direct Revenue Growth | +5.00% | +24.09% | n/a |
| Products & Healthcare Services Revenue | 8.02B | 7.78B | 7.9B |
| Products & Healthcare Services Revenue Growth | +3.08% | -1.48% | n/a |
Revenue by Geography
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Us Revenue | 242.94M | 275.29M | 429.44M | 534.98M | 349.77M | 339.34M | 577.56M | 8.9B | 9.34B | 9.36B | 8.95B | 8.69B |
| Non-Us Revenue Growth | -11.75% | -35.89% | -19.73% | +52.95% | +3.07% | -41.25% | -93.51% | -4.70% | -0.19% | +4.52% | +3.04% | n/a |
| United States Revenue | 10.46B | 10.06B | 9.53B | 9.25B | 8.13B | 8.87B | 9.26B | n/a | n/a | n/a | n/a | n/a |
| United States Revenue Growth | +3.97% | +5.59% | +2.98% | +13.77% | -8.35% | -4.21% | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 462.35M | 493.07M | 469.8M | 421.73M | 423.82M | 457.23M | 452.58M | 455.03M | 448.72M | 455.86M | 445.26M | 452.81M | 279.74M | 267.62M | 262.46M | 294.1M | 292.7M | 283.02M | 262.54M | 241.73M | 254.05M | 254.16M | 332.37M | 345.89M | 338.7M | 343.6M | 325.01M | 308.77M | 284.36M | 281.63M | 261.05M | 236.62M | 237.69M | 243.48M | 241.31M | 242.91M | 242.72M | 236.43M | 231.85M | 231.5M | 233.82M |
| Selling, General, and Administrative Revenue Growth | -6.23% | +4.95% | +11.40% | -0.49% | -7.31% | +1.03% | -0.54% | +1.41% | -1.56% | +2.38% | -1.67% | +61.87% | +4.53% | +1.97% | -10.76% | +0.48% | +3.42% | +7.80% | +8.61% | -4.85% | -0.05% | -23.53% | -3.91% | +2.12% | -1.43% | +5.72% | +5.26% | +8.59% | +0.97% | +7.88% | +10.32% | -0.45% | -2.38% | +0.90% | -0.66% | +0.08% | +2.66% | +1.98% | +0.15% | -1.00% | n/a |
| Research and Development Revenue | n/a | n/a | n/a | n/a | n/a | 13.2M | n/a | n/a | n/a | 11.8M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Research and Development Revenue Growth | n/a | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |